2.50
Hdl Handle:
http://hdl.handle.net/10143/35973
Title:
Use of evidence in WHO recommendations.
Authors:
Oxman, Andrew David; Lavis, John N; Fretheim, Atle
Citation:
Lancet 2007, 369 (9576):1883-9

Full metadata record

DC FieldValue Language
dc.contributor.authorOxman, Andrew David-
dc.contributor.authorLavis, John N-
dc.contributor.authorFretheim, Atle-
dc.date.accessioned2008-08-20T13:07:52Z-
dc.date.available2008-08-20T13:07:52Z-
dc.date.issued2007-06-02-
dc.identifier.citationLancet 2007, 369 (9576):1883-9en
dc.identifier.issn1474-547X-
dc.identifier.pmid17493676-
dc.identifier.doi10.1016/S0140-6736(07)60675-8-
dc.identifier.urihttp://hdl.handle.net/10143/35973-
dc.description.abstractBACKGROUND: WHO regulations, dating back to 1951, emphasise the role of expert opinion in the development of recommendations. However, the organisation's guidelines, approved in 2003, emphasise the use of systematic reviews for evidence of effects, processes that allow for the explicit incorporation of other types of information (including values), and evidence-informed dissemination and implementation strategies. We examined the use of evidence, particularly evidence of effects, in recommendations developed by WHO departments. METHODS: We interviewed department directors (or their delegates) at WHO headquarters in Geneva, Switzerland, and reviewed a sample of the recommendation-containing reports that were discussed in the interviews (as well as related background documentation). Two individuals independently analysed the interviews and reviewed key features of the reports and background documentation. FINDINGS: Systematic reviews and concise summaries of findings are rarely used for developing recommendations. Instead, processes usually rely heavily on experts in a particular specialty, rather than representatives of those who will have to live with the recommendations or on experts in particular methodological areas. INTERPRETATION: Progress in the development, adaptation, dissemination, and implementation of recommendations for member states will need leadership, the resources necessary for WHO to undertake these processes in a transparent and defensible way, and close attention to the current and emerging research literature related to these processes.en
dc.language.isoenen
dc.subjectVDP::Medisinske Fag: 700::Helsefag: 800::Helsetjeneste- og helseadministrasjonsforskning: 806en
dc.subjectVDP::Medisinske Fag: 700::Helsefag: 800::Samfunnsmedisin, sosialmedisin: 801en
dc.subject.meshEvidence-Based Medicineen
dc.subject.meshExpert Testimonyen
dc.subject.meshHealth Planning Guidelinesen
dc.subject.meshHealth Policyen
dc.subject.meshHumansen
dc.subject.meshInterviews as Topicen
dc.subject.meshPhysician Executivesen
dc.subject.meshWorld Health Organizationen
dc.titleUse of evidence in WHO recommendations.en
dc.typeJournal articleen
dc.typepeer revieweden
dc.contributor.departmentNorwegian Knowledge Centre for the Health Services, PO Box 7004, St Olavs plass, N-0130 Oslo, Norway. oxman@online.noen
dc.identifier.journalLanceten
All Items in HeRA are protected by copyright, with all rights reserved, unless otherwise indicated.